Title:
FAP INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2023/202655
Kind Code:
A1
Abstract:
Provided herein are a compound of Formula (I), a pharmaceutical composition comprising said compound, and method of use of the compound or pharmaceutical composition in the diagnosis or treatment of a disease characterized by overexpression of fibroblast activation protein (FAP).
Inventors:
JIN YUN (CN)
Application Number:
PCT/CN2023/089429
Publication Date:
October 26, 2023
Filing Date:
April 20, 2023
Export Citation:
Assignee:
SHANGHAI SINOTAU BIOTECH CO LTD (CN)
International Classes:
C07D401/14; A61K31/403; A61P35/00
Domestic Patent References:
| WO2021090245A1 | 2021-05-14 | |||
| WO2022066774A1 | 2022-03-31 | |||
| WO2019083990A2 | 2019-05-02 |
Foreign References:
| US20210038749A1 | 2021-02-11 |
Attorney, Agent or Firm:
AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
Previous Patent: COMPOUND AND USE THEREOF
Next Patent: SYSTEM FOR PREDICTING A STATE OF INJURIES OF A VULNERABLE ROAD USER FOR A VEHICLE AND VEHICLE
Next Patent: SYSTEM FOR PREDICTING A STATE OF INJURIES OF A VULNERABLE ROAD USER FOR A VEHICLE AND VEHICLE